Aktienführer
LION bioscience Aktiengesellschaft (Q2234): Difference between revisions

LION bioscience Aktiengesellschaft (Q2234): Difference between revisions

(‎Created a new Item)
 
(No difference)

Latest revision as of 12:29, 31 March 2023

No description defined
  • LION bioscience Aktiengesellschaft
  • SYGNIS Pharma AG
Language Label Description Also known as
English
LION bioscience Aktiengesellschaft
No description defined
  • LION bioscience Aktiengesellschaft
  • SYGNIS Pharma AG

Statements

ticker symbol
2INV
0 references
official name
LION bioscience Aktiengesellschaft (German)
start time
2001
end time
2006
1 reference
Aktienführer ID
2001.2.0739
SYGNIS Pharma AG (German)
start time
2007
end time
2011
1 reference
Aktienführer ID
2001.2.0739

Identifiers

European VAT number
DE812225682
0 references
GND ID
10185538-2
0 references
WKN
504350
1 reference
Aktienführer ID
2001.2.0739
Crefo number
7050151257
0 references
BvD ID
DE7050151257
0 references
BvD Abschlussnummer
DE7050151257IU
0 references
Orbis ID
2667205
0 references
VIAF ID
140577506
0 references
Handelsregisternummer
HRB 335706 (Mannheim)
0 references
 
Retrieved from "https://akf.kgi.uni-mannheim.de/w/index.php?title=Item:Q2234&oldid=2584"